Skip to content

Clinical trials

Purpura, Thrombocytopenic, Idiopathic trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Purpura, Thrombocytopenic, Idiopathic Country / region: Australia Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20073
20091
20101
20111
20122
20144
20181
20203
20211
20221
20233
20243
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Recruiting5
Active, not recruiting3
Terminated2
Withdrawn2
Enrolling by invitation1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen4
Novartis Pharmaceuticals3
Chugai Pharmaceutical2
Principia Biopharma, a Sanofi Company2
Rigel Pharmaceuticals2
Takeda2
argenx2
Alpine Immune Sciences Inc, A Subsidiary of Vertex1
Bristol-Myers Squibb1
CSL Limited1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Purpura, Thrombocytopenic, Idiopathic29
Thrombocytopenia7
Hematologic Diseases5
Autoimmune Diseases4
Hemorrhage4
Purpura4
Purpura, Thrombocytopenic4
Anemia, Hemolytic, Autoimmune3
Blood Platelet Disorders3
Hemorrhagic Disorders3

Trials

Showing 76 to 29 of 29. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.